BioSafety Level 3

The Vanderbilt University Medical Center has received $8 million in funding from the National Institutes of Health and has allotted an additional $4 million to establish a new biosafety level 3 laboratory on campus. This funding was possible thanks in large part to the efforts of Eric Skaar, director of VI4—the Vanderbilt Institute for Infection, Immunology and Inflammation—as well as the VUMC Office of Research. Read More

Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. VUMC currently has two BSL3 labs, but they are small, outdated and… Read More